Clinical Trial Update: Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating erythropoietin for anemia due to zidovudine in HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Anemia

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Acquired Immunodeficiency Syndrome, Anemia | Phase 2 | Status: COMPLETED